sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
22-Oct-2014 22:26
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 576-600 out of 904.

<< < 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>

Public Release: 23-Jul-2013
Applied and Environmental Microbiology
Natural pest control protein effective against hookworm: A billion could benefit
A benign crystal protein, produced naturally by bacteria and used as an organic pesticide, could be a safe, inexpensive treatment for parasitic worms in humans and provide effective relief to over a billion people around the world. Researchers from the University of California, San Diego, La Jolla, CA, report on this potentially promising solution in a study published ahead of print in the journal Applied and Environmental Microbiology.

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology

Public Release: 23-Jul-2013
Cell Host & Microbe
Mount Sinai researchers identify vulnerabilities of the deadly Ebola virus
Disabling a protein in Ebola virus cells can stop the virus from replicating and infecting the host, according to researchers from the Icahn School of Medicine at Mount Sinai.

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 23-Jul-2013
University of Tennessee professors explore end-of-life needs for HIV/AIDS patients
Approximately 10,000 Americans die with an HIV/AIDS diagnosis each year, and many of these patients lack access to the care they need at the end of their lives. This is especially true for those who live in the Appalachian region. A group of nursing professors at the University of Tennessee, Knoxville, is embarking on a study to try to change this.
National Institutes of Health

Contact: Whitney Heins
wheins@utk.edu
865-974-5460
University of Tennessee at Knoxville

Public Release: 22-Jul-2013
Proceedings of the National Academy of Sciences
Off-grid sterilization with Rice U.'s 'solar steam'
Rice University nanotechnology researchers have unveiled a solar-powered sterilization system that could be a boon for more than 2.5 billion people who lack adequate sanitation. The "solar steam" sterilization system uses nanomaterials to convert as much as 80 percent of the energy in sunlight into germ-killing heat. The technology is described online in the Proceedings of the National Academy of Sciences Early Edition.
Bill & Melinda Gates Foundation, Welch Foundation

Contact: David Ruth
david@rice.edu
713-348-6327
Rice University

Public Release: 22-Jul-2013
mBio
Study lays groundwork for norovirus anti-viral treatments
There's no vaccine to prevent norovirus, or drugs to treat the pesky virus that sickens millions each year and is known to complicate cruise ship vacations. But a first ever small animal model created at the University of Michigan Medical School provides a new tool to develop anti-viral treatments.
National Institutes of Health

Contact: Shantell M. Kirkendoll
smkirk@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 19-Jul-2013
PLOS Currents
Researchers describe potential for MERS coronavirus to spread internationally
The life-threatening MERS coronavirus that has emerged in the Middle East could spread faster and wider during two international mass gatherings involving millions of people in the next few months, according to researchers who describe the most likely pathways of international spread based upon worldwide patterns of air travel.
Canadian Institutes of Health Research, US Centers for Disease Control and Prevention

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital

Public Release: 19-Jul-2013
Science Translational Medicine
The genetic key to conquering cholera
Researchers have long understood that genetics can play a role in how susceptible people are to contracting cholera, but a team of Harvard scientists is now uncovering evidence of genetic changes that might also help protect some people from contracting the deadly disease.

Contact: Peter Reuell
preuell@fas.harvard.edu
617-496-8070
Harvard University

Public Release: 17-Jul-2013
Nutrition for Growth Summit
Conflict threatens global nutrition progress, new report warns
Major progress in tackling child undernutrition in some of the world's toughest countries is under threat as military and security funding takes precedence, a new report from aid agency World Vision warns.

Contact: Holly Frew
hfrew@worldvision.org
202-596-8509
World Vision

Public Release: 16-Jul-2013
Health Affairs
Health Affairs July issue contains global innovation studies from India And Brazil
Two new studies, in Health Affairs July 2013 issue, describe health success stories outside the US.

Contact: Sue Ducat
sducat@projecthope.org
301-841-9962
Health Affairs

Public Release: 16-Jul-2013
Research leads to affordable technology to fight mosquito-borne diseases
Technology that hampers mosquitoes' host-seeking behavior, identified at the University of California, Riverside in 2011, has led to the development of the world's first product that blocks mosquitoes' ability to efficiently detect carbon dioxide, their primary method of tracking human blood meals.
Bill and Melinda Gates Foundation, National Institutes of Health

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 12-Jul-2013
PLOS Neglected Tropical Diseases
Exploring gender dimensions of treatment programs for neglected tropical diseases in Uganda
Males and females face different challenges in accessing treatment for neglected tropical diseases, according to a new study from researchers at the University of Toronto Dalla Lana School of Public Health, Uganda Ministry of Health and Imperial College London. The study, published by PLOS Neglected Tropical Diseases on July 11, explores the role of gender in access to treatment in the Uganda National Neglected Tropical Disease Control Program.

Contact: Heather Rilkoff
heather.rilkoff@mail.utoronto.ca
647-206-8328
University of Toronto

Public Release: 11-Jul-2013
Nucleic Acid Therapeutics
New therapeutic strategy targets dengue virus using artificial microRNAs
Mosquito-borne dengue viruses cause an estimated 50 million cases of human dengue fever a year and are a significant public health threat worldwide.

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 11-Jul-2013
3 neglected-disease treatments newly added to WHO Essential Medicines List for paediatric use
This week the World Health Organization (WHO) released its newly updated 4th WHO Model List of Essential Medicines for Children, in which three treatments developed by the Drugs for Neglected Diseases initiative and its partners have now been included. One treatment was also added to the 18th WHO Model List of Essential Medicines for adults.

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 10-Jul-2013
Molecular Biology and Evolution
Malaria in the Americas presents a complex picture
In a new study, Ananias Escalante and an international team explore the genetic diversity of malarial parasite P. vivax in the Americas and other areas of the world. The study shows greater genetic diversity for P. vivax compared with earlier studies and points to plausible routes of malarial introduction into the New World.

Contact: Joseph Caspermeyer
Joseph.Caspermeyer@asu.edu
Arizona State University

Public Release: 10-Jul-2013
University of North Carolina receives $8 million grant to improve safe motherhood in Malawi
The University of North Carolina at Chapel Hill has received a five-year, $8 million grant from the Bill & Melinda Gates Foundation to improve maternal and infant health and save the lives of mothers and infants in Malawi by strengthening the President's Maternal Health and Safe Motherhood Initiative.
Bill & Melinda Gates Foundation

Contact: Lisa Chensvold
lisa_chensvold@med.unc.edu
919-843-5719
University of North Carolina Health Care

Public Release: 10-Jul-2013
Genome Research
Researchers create method to rapidly identify specific strains of illness
Researchers from Boston University School of Medicine and George Washington University have developed a method to rapidly identify pathogenic species and strains causing illnesses, such as pneumonia, that could help lead to earlier detection of disease outbreaks and pinpoint effective treatments more quickly.

Contact: Gina Orlando
gina.orlando@bmc.org
617-638-8490
Boston University Medical Center

Public Release: 9-Jul-2013
PLOS ONE
Bird vaccine for West Nile Virus
University of British Columbia researchers have developed a vaccine to halt the spread of West Nile Virus among common and endangered bird species.

Contact: Brian Lin
brian.lin@ubc.ca
604-822-2234
University of British Columbia

Public Release: 8-Jul-2013
Global Health Corps announces fifth class of fellows
Global Health Corps launched its fifth class of fellows today, during the opening of its annual Training Institute at Yale University. The 106 fellows hail from 16 countries and will serve with 44 health organizations in Burundi, Malawi, Rwanda, Uganda, Zambia and select cities in the United States. The newest fellowship class was selected from a pool of almost 4,000 applicants and highlights GHC's continued growth.

Contact: Anne McPherson
anne@ghcorps.org
917-531-4050
Global Health Strategies

Public Release: 8-Jul-2013
Annals of Internal Medicine
Annals of Internal Medicine tip Sheet for 9 July 2013
Below is information about articles being published in the July 9 issue of Annals of Internal Medicine. The information is not intended to substitute for the full article as a source of information. Annals of Internal Medicine attribution is required for all coverage.

Contact: Megan Hanks
mhanks@acponline.org
215-351-2656
American College of Physicians

Public Release: 3-Jul-2013
Journal of Royal Society Interface
Research team improves immunization strategies for dengue fever in Thailand
Results have implications for designing more effective vaccine studies, says UMass Amherst biostatistician Nicholas Reich, who led the team. Dengue fever is a mosquito-transmitted viral infection that sickens 5 percent of the world's population each year and recently has begun to emerge in parts of the southeast United States. They report the first explicit quantitative evidence that short-term cross-protection exists since human experimental infection studies performed in the 1940s and 1950s by Albert Sabin.
NIH/National Institute of General Medical Sciences, Gates Foundation Vaccine Modeling Initiative

Contact: Janet Lathrop
jlathrop@admin.umass.edu
413-545-0444
University of Massachusetts at Amherst

Public Release: 3-Jul-2013
Science Translational Medicine
Genetic signals reflect the evolutionary impact of cholera
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the Vibrio cholerae bacteria.
National Institutes of Health, Howard Hughes Medical Institute, American Cancer Society, Packard Foundation

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital

Public Release: 2-Jul-2013
Bringing low-cost, inkjet-printed nano test strips to pakistan for drinking water tests
The National Academy of Sciences announced a three-year, $271,930 grant to chemist Vincent Rotello at the University of Massachusetts Amherst to develop, test and deploy new, sensitive, reliable and affordable inkjet-printed, nanoparticle-based test strips for detecting disease-causing bacteria in drinking water, with researchers at the Lahore University of Management Sciences, Pakistan.
US National Academy of Sciences

Contact: Janet Lathrop
jlathrop@admin.umass.edu
413-545-0444
University of Massachusetts at Amherst

Public Release: 1-Jul-2013
New guidelines pave the road for achieving an AIDS-free generation
The Elizabeth Glaser Pediatric AIDS Foundation welcomes the World Health Organization's new HIV/AIDS treatment and prevention guidelines. For the first time, the 2013 guidelines combine recommendations across the continuum of HIV care and prevention programs, including expanding treatment eligibility for HIV-positive pregnant women, mothers, and children. These recommendations signify a major step forward in the global effort to achieve an AIDS-free generation, but will require a significant shift in current implementation efforts.

Contact: Johanna Harvey
jharvey@pedaids.org
202-280-1657
Elizabeth Glaser Pediatric AIDS Foundation

Public Release: 1-Jul-2013
Journal of Clinical Investigation
Cross-species malaria immunity induced by chemically attenuated parasites
In this issue of the Journal of Clinical Investigation, Michael Good and colleagues demonstrate that mice inoculated with a single species of attenuated parasite display immunity to multiple malaria species for over 100 days.
National Health and Medical Research Council Australia Fellowship, Griffith University

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 30-Jun-2013
7th IAS Conference on HIV Pathogenesis, Treatment and Prevention
DNDi and Cipla advance development of pediatric 4-in-1 ARVs to fulfill new WHO guidelines
The World Health Organization's new HIV treatment guidelines, released today at the 2013 International AIDS Society Conference, include new antiretroviral therapy recommendations for HIV-infected children, and will mean that more children will be on better treatments. The Drugs for Neglected Diseases initiative applauds the new guidelines and, with Cipla Ltd. and other partners, is expediting the development of urgently needed 4-in-1 ARVs adapted for babies and toddlers with HIV, to be delivered by 2015.

Contact: Oliver Yun
oyun@dndi.org
646-266-5216
Drugs for Neglected Diseases Initiative

Showing releases 576-600 out of 904.

<< < 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>